Brady Corporation Reports 2026 Fourth Quarter and Record Full Year Results
Source: globenewswire.com

Brady reported record annual revenue and fiscal 2026 fourth-quarter/year results, and it completed the Aug. 3, 2026 acquisition of Honeywell Technologies’ Productivity Solutions and Services business. For fiscal 2027, Brady guided adjusted diluted EPS growth of 23% at the midpoint of its range. The combination of record results plus an EPS growth outlook supports a constructive near-term outlook for the stock.
Analysis
The market will likely treat this as a self-help re-rating story, but the important mechanism is mix, not headline EPS. If the acquired workflow assets deepen BRC’s installed base and pull through higher-margin consumables/software, the company can move from a low-growth industrial to a sticky recurring-revenue profile, which deserves a higher multiple than a pure hardware/label vendor.
The second-order loser is not just the direct product competitor set; it is any smaller industrial identification supplier that competes on price and lacks software adjacency. Zebra (ZBRA) is the cleanest public proxy to watch, but the bigger tell will be whether BRC can sustain margin expansion after purchase accounting and integration costs, because acquisition-driven guidance often looks better than underlying demand. If organic growth stays subdued, the EPS step-up will be viewed as financial engineering rather than durable acceleration.
The contrarian issue is that the stock may already be pricing the optimism embedded in the FY27 guide, while the real risk sits in the next two quarters: working-capital drag, integration execution, and any reset in synergy timing. A sustained move higher needs proof of conversion on free cash flow and leverage reduction; without that, the multiple can compress even if reported EPS beats. The thesis is falsified if organic revenue growth slips back to low single digits or if management is forced to temper synergy expectations on the next update.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.40
Ticker Sentiment
Key Decisions for Investors
- Buy BRC on a 5-8% post-print pullback over the next 1-3 weeks; target 15-20% upside over 6-12 months if management shows credible synergy capture and deleveraging. Stop/trim if organic growth or gross margin sequencing disappoints in the next quarter.
- Pair trade: long BRC / short ZBRA for 1-2 quarters if you expect BRC’s new bundle to gain share in industrial labeling and asset-tracking workflows. This works best if BRC can show faster margin expansion while ZBRA remains tied to a slower warehouse capex cycle.
- If BRC rallies more than 10% immediately, fade the move with a short-dated call spread or take profits. The market is likely to overpay for EPS that is partly acquisition-driven until free cash flow and leverage trends are verified.
More News
- Nvidia in talks to invest up to $10 billion in Anthropic IPO
- The inside story on the historic U.S.-Venezuela oil deal and how it will work
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Surging cloud revenue boosted Oracle’s quarterly results. Here’s what analysts are saying
- Exclusive-Nvidia in talks to invest in Anthropic’s mega IPO, sources say
- Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports